Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics parp'

Search results for: 'research area epigenetics parp'

Items 1-10 of 45

Page
per page
  1. AZD2461
    A4164 AZD2461
    Target: PARP
    Summary: Novel PARP inhibitor
      insoluble in H2O; ≥16.35 mg/mL
  2. PJ34
    A3729 PJ34
    Target: PARP
    Summary: PARP-l inhibitor
      ≥50.9 mg/mL
  3. UPF 1069
    A4163 UPF 1069
    Target: PARP
    Summary: Selective PARP2 inhibitor
      insoluble in H2O; ≥12.7 mg/mL
  4. Vorinostat (SAHA, MK0683)
    A4084 Vorinostat (SAHA, MK0683)
     9 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
  5. Mocetinostat (MGCD0103, MG0103)
    A4089 Mocetinostat (MGCD0103, MG0103)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,isotype-selective and potent
      insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
  6. AZD1208
    A3962 AZD1208
    Target: Pim
    Summary: PIM kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥18.95 mg/mL
  7. Tubacin
    A4501 Tubacin
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent,selective,reversible,cell-permeable
      insoluble in EtOH; insoluble in H2O; ≥7.19 mg/mL
  8. Tenovin-6
    A8302 Tenovin-6
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT inhibitor and p53 activator
      ≥22.75 mg/mL
  9. SRT2104 (GSK2245840)
    A3821 SRT2104 (GSK2245840)
     1 Citation
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT1 activator,selective
      insoluble in H2O; insoluble in EtOH; ≥6.46 mg/mL
  10. Ruxolitinib (INCB018424)
    A3012 Ruxolitinib (INCB018424)
     4 Citation
    Target: JAK
    Summary: JAK inhibitor
      insoluble in H2O; ≥15.32 mg/mL

Items 1-10 of 45

Page
per page
Shop By
Now Shopping by
  1. Category Chromatin/Epigenetics Remove This Item
  2. Specificity Selective Remove This Item
  3. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Bromodomain 2item
  2. Aurora Kinase 7item
  3. DNA Methyltransferase 3item
  4. HDAC 15item
  5. Histone Demethylases 1 item
  6. Histone Methyltransferase 4item
  7. HIF 1 item
  8. JAK 4item
  9. PARP 3item
  10. Pim 1 item
  11. Protein Ser/Thr Phosphatases 1 item
  12. Sirtuin 4item
Reversibility
  1. Reversible 2item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 15item
  3. Aurora Kinases 7item
  4. EZH2 1 item
  5. Bromodomains 1 item
  6. FLT3 1 item
  7. Hydrolase 1 item
  8. DOT1L 1 item
  9. Nrf2 1 item
  10. Pim 1 item
  11. Sir2-like Family Deacetylases (Sirtuins) 3item
  12. PP1 1 item
  13. PP2A 1 item
  14. JAK 3item
  15. Topoisomerases 1 item
  16. DNA Methyltransferases 2item
  17. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  18. CREBBP 1 item
  19. EP300 1 item
  20. PARP 3item
  21. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  22. Cytidine deaminases 1 item
  23. PP4 1 item
  24. c-RET 1 item
  25. Sirtuin 1 item
Related Disease
  1. Acute Myeloid Leukemia 7item
  2. Bladder Cancer 2item
  3. Bladder Carcinoma 1 item
  4. Breast Cancer 11item
  5. Cancer 31item
  6. Cervical Cancer 1 item
  7. Chronic Lymphocytic Leukemia 1 item
  8. Colon Cancer 5item
  9. Colorectal Cancer 3item
  10. Glioblastoma 1 item
  11. Glioma 2item
  12. Hepatic Cancer 1 item
  13. Hepatocellular Carcinoma 1 item
  14. HIV Infections 1 item
  15. Inflammatory Diseases 1 item
  16. Leukemia 3item
  17. Lung Cancer 4item
  18. Lymphoma 1 item
  19. Melanoma 1 item
  20. Mixed Lineage Leukemia 1 item
  21. Multiple Myeloma 3item
  22. Myelofibrosis 1 item
  23. Myeloma 1 item
  24. Neuroblastoma 1 item
  25. Neuronal Protection 1 item
  26. Non-small Cell Lung Cancer 1 item
  27. Ovarian Cancer 4item
  28. Pancreatic Cancer 2item
  29. Prostate Cancer 9item
  30. Psoriasis 1 item
  31. Renal Cancer 1 item
  32. Renal Cell Carcinoma 2item
  33. Rheumatoid Arthritis 2item
  34. Thyroid Cancer 1 item
  35. Type 2 Diabetes 2item